Find information on thousands of medical conditions and prescription drugs.

Vistide

Cidofovir is an injectable antiviral medication for the treatment of cytomegalovirus (CMV) retinitis in patients with AIDS. It suppresses CMV replication by selective inhibition of viral DNA synthesis. more...

Home

Vagifem

Valcyte

Valine

Valium

Valstar

Valtrex

Vaniqa

Velcade

Velivet

Venlafaxine

Ventolin

Vepesid

Verapamil

Verelan

Vermox

Versed

Vfend

Viadur

Viagra

Vicoprofen

Vidarabine

Vidaza

Videx

Vioxx

Viread

Visine

Vistide

Visudyne

Vitaped

Vitrase

Vivelle

Volmax

Voltaren

Voriconazole

Vosol

Cidofovir demonstrated a statistically significant effect in delaying the progression of CMV retinitis lesions in newly diagnosed patients, as well as in previously treated patients who had failed other therapies. Maintenance therapy with cidofovir involves an infusion only once every two weeks, making it a convenient treatment option. Because dosing is relatively infrequent, a permanent catheter is not necessary for infusions.

Cidofovir has also been investigated as a treatment for progressive multifocal leukoencephalopathy, but as of 2005 studies are inconclusive.

Cidofovir was developed by Gilead Sciences and is marketed with the brand name Vistide by Gilead in the USA, and by Pfizer elsewhere.

Read more at Wikipedia.org

• [List your site here Free!]



	Gilead Sciences, Inc - Corporate Capabilities Company description Gilead Sciences is an independent biopharmaceutical company that discovers, develops, and commercializes therapeutics to advance ... From Pharmaceutical Technology, 12/1/03

	Managing viral conjunctivitis: A primer How to identify and treat the most common infections your practice will see. Although innumerable viral entities can infect the human host, adenoviruses ... From Optometric Management, 11/1/03 by Gupta, Deepak

	Smallpox vaccine: contraindications, administration, and adverse reactions Since the terrorist attacks of September 11, 2001, and the anthrax exposures in the following weeks, concern that smallpox could be used as a biologic ... From American Family Physician, 9/1/03 by Douglas M. Maurer

	Cytomegalovirus Cytomegalovirus (CMV) is a prevalent viral pathogen. The majority of persons with acute CMV will experience an inapparent infection. Primary CMV infection ... From American Family Physician, 2/1/03 by Gregory H. Taylor

	AAP statement on smallpox vaccine - Brief Article Isolating persons infected with smallpox and immunizing those who had contact with them is the best strategy for containing a potential outbreak of the disease, according to a new policy statement From American Family Physician, 1/1/03 by Carrie Morantz

	Brave new drug: compound stops cowpox and smallpox viruses - Brief Article By cloaking an antiviral drug in a fat molecule, scientists have developed a new compound that people might someday swallow to ward off smallpox. A vaccine against smallpox exists, but government From Science News, 3/23/02 by N. Seppa

	Strengthening National Preparedness for Smallpox: An Update Concern that smallpox virus may be used as a biological weapon of mass destruction has prompted calls for production of additional vaccine and new research ... From Emerging Infectious Diseases, 1/1/01 by James W. LeDuc

	Successful Treatment of Juvenile Laryngeal Papillomatosis-Related Multicystic Lung Disease With Cidofovir - ) Case Report and Review of the Literature Cidofovir, a nucleoside analog antiviral agent, has been used with moderate success in the treatment of juvenile ... From CHEST, 10/1/00 by David R. Dancey

Home

Contact

Resources

Exchange Links

ebay